The percentage of CD68+ macrophages was gradually elevated in BMB samples of CML patients with CML-CP (27.03 ± 3.90)%, CML-AP (44.64 ± 4.84)%, and CML-BP groups (66.98 ± 6.28)% (Figures 1(a), 1(b), 2(c), and 1(d)), respectively. Here, CD68 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.